<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35264003</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1746-0921</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Future microbiology</Title><ISOAbbreviation>Future Microbiol</ISOAbbreviation></Journal><ArticleTitle>Long-term outcomes of pediatric infections: from traditional infectious diseases to&#xa0;long&#xa0;Covid.</ArticleTitle><Pagination><StartPage>551</StartPage><EndPage>571</EndPage><MedlinePgn>551-571</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2217/fmb-2022-0031</ELocationID><Abstract><AbstractText>There is limited evidence available on the long-term impact of SARS-CoV-2 infection in children. In this article, the authors&#xa0;analyze the&#xa0;recent evidence on pediatric long Covid and lessons learnt from a pediatric post-Covid unit in Rome, Italy. To gain a better understanding of the concerns raised by parents and physicians in relation to the potential long-term consequences of this novel infection, it is important to recognize that long-term effect&#xa0;of a&#xa0;post-infectious disease is not a new phenomenon.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8567-2639</Identifier><AffiliationInfo><Affiliation>Department of Woman &amp; Child Health &amp; Public Health, Fondazione Policlinico Universitario A&#xa0;Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Global Health Research &amp; Studies, Universit&#xe0; Cattolica del Sacro Cuore, Roma, Italia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Gennaro</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Imaging, Hemorrhagic &amp; Thrombotic Diseases Center, Oncological Radiotherapy, &amp; Hematology, Foundation 'A&#xa0;Gemelli' IRCCS University Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rose</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Woman &amp; Child Health &amp; Public Health, Fondazione Policlinico Universitario A&#xa0;Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Woman &amp; Child Health &amp; Public Health, Fondazione Policlinico Universitario A&#xa0;Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ilario</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Woman &amp; Child Health &amp; Public Health, Fondazione Policlinico Universitario A&#xa0;Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zampino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Woman &amp; Child Health &amp; Public Health, Fondazione Policlinico Universitario A&#xa0;Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piazza</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Section, Department of Surgery, Dentistry, pediatrics, &amp; Gynaecology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boner</LastName><ForeName>Attilio L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Pediatric Section, Department of Surgery, Dentistry, pediatrics, &amp; Gynaecology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iraci</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Patient author, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connell</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Patient author, UK &amp; Northern Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Valentina B</ForeName><Initials>VB</Initials><AffiliationInfo><Affiliation>Patient author, member of the CAC Community Advisory Council of Solve ME/CFS Initiative, Pietro Barilla Children's Hospital, Department of Medicine &amp; Surgery, University of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esposito</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pietro Barilla Children's Hospital, Department of Medicine &amp; Surgery, University of Parma, Via Gramsci 14, Parma, 43126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munblit</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of pediatrics &amp; pediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reena</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MSc Immunology, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigfrid</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ISARIC Global Support Centre, Centre for Tropical Medicine &amp; Global Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Woman &amp; Child Health &amp; Public Health, Fondazione Policlinico Universitario A&#xa0;Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Future Microbiol</MedlineTA><NlmUniqueID>101278120</NlmUniqueID><ISSNLinking>1746-0913</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="Y">Communicable Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>The authors analyze the&#xa0;recent evidence on pediatric long Covid and lessons learnt from a pediatric post-Covid unit in Rome, Italy. Also, we analyze the long-term effects of other infectious diseases.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">long Covid</Keyword><Keyword MajorTopicYN="N">microclots</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">viral persistence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35264003</ArticleId><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="doi">10.2217/fmb-2022-0031</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kumar A, Narayan RK, Prasoon P et al. COVID-19 mechanisms in the human body-what we know so far. Front. Immunol. 12, 693938 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8592035</ArticleId><ArticleId IdType="pubmed">34790191</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Baricich A, Patrucco F et al. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Sci. Rep. 11(1), 22666 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8608998</ArticleId><ArticleId IdType="pubmed">34811387</ArticleId></ArticleIdList></Reference><Reference><Citation>Word Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bem RA, Bont LJ, van Woensel JBM. Life-threatening bronchiolitis in children: eight decades of critical care. Lancet. Respir. Med. 8(2), 142&#x2013;144 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32035065</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Gu W, Wu M et al. Risk factors for recurrent wheezing after bronchiolitis in infants: 2-year follow up in China. BMC Infect. Dis. 21(1), 250 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7945297</ArticleId><ArticleId IdType="pubmed">33691633</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Tong L, Li M et al. Recurrent wheezing and asthma after respiratory syncytial virus bronchiolitis. Front. Pediatr. 9, 649003 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8211724</ArticleId><ArticleId IdType="pubmed">34150683</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Zhang X, Zhang N et al. Airway microbiome, host immune response and recurrent wheezing in infants with severe respiratory syncytial virus bronchiolitis. Pediatr. Allergy. Immunol. 31(3), 281&#x2013;289 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31788862</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitcharoensakkul M, Bacharier LB, Yin-Declue H et al. Impaired tumor necrosis factor-&#x3b1; secretion by CD4 T cells during respiratory syncytial virus bronchiolitis associated with recurrent wheeze. Immun. Inflamm. Dis. 8(1), 30&#x2013;39 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7016853</ArticleId><ArticleId IdType="pubmed">31901157</ArticleId></ArticleIdList></Reference><Reference><Citation>Makrinioti H, Bush A, Gern J et al. The role of interferons in driving susceptibility to asthma following bronchiolitis: controversies and research gaps. Front. Immunol. 12, 761660 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8677668</ArticleId><ArticleId IdType="pubmed">34925333</ArticleId></ArticleIdList></Reference><Reference><Citation>Junker Anne K. Epstein-Barr virus. Pediatrics in Review. 26(3), 79&#x2013;85 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15743754</ArticleId></ArticleIdList></Reference><Reference><Citation>Fugl A, Andersen CL. Epstein-Barr virus and its association with disease &#x2013; a review of relevance to general practice. BMC Fam. Pract. 20(1), 62 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6518816</ArticleId><ArticleId IdType="pubmed">31088382</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon-Lowe C, Rickinson A. The global landscape of EBV-associated tumors. Front. Oncol. 9, 713 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6691157</ArticleId><ArticleId IdType="pubmed">31448229</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow SH, Campo E, Pileri SA et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20), 2375&#x2013;2390 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4874220</ArticleId><ArticleId IdType="pubmed">26980727</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques-Piubelli ML, Salas YI, Pachas C, Becker-Hecker R, Vega F, Miranda RN. Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review. Pathology 52(1), 40&#x2013;52 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31706670</ArticleId></ArticleIdList></Reference><Reference><Citation>Montes-Mojarro IA, Kim WY, Fend F, Quintanilla-Martinez L. Epstein&#x2013;Barr virus positive T and NK-cell lymphoproliferations: morphological features and differential diagnosis. Semin. Diagn. Pathol. 37(1), 32&#x2013;46 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31889602</ArticleId></ArticleIdList></Reference><Reference><Citation>Campion NJ, Ally M, Jank BJ, Ahmed J, Alusi G. The molecular march of primary and recurrent nasopharyngeal carcinoma. Oncogene 40(10), 1757&#x2013;1774 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33479496</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos. Trans. R. Soc. Lond. B. Biol Sci. 372(1732), 20160270 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5597737</ArticleId><ArticleId IdType="pubmed">28893937</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang CM, Lui VWY, Bruce JP, Pugh TJ, Lo KW. Translational genomics of nasopharyngeal cancer. Semin. Cancer. Biol. 61, 84&#x2013;100 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31521748</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E, Reshkova V, Kumanova A et al. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic encephalomyelitis/chronic fatigue syndrome. J. Med. Virol. 92(12), 3682&#x2013;3688 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687071</ArticleId><ArticleId IdType="pubmed">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr JR. Epstein-Barr virus-induced gene-2 upregulation identifies a particular subtype of chronic fatigue syndrome/myalgic encephalomyelitis. Front. Pediatr. 7, 59 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6424879</ArticleId><ArticleId IdType="pubmed">30918887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr J. Early growth response gene upregulation in Epstein-Barr virus (EBV)-associated myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Biomolecules 10(11), 1484 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7692278</ArticleId><ArticleId IdType="pubmed">33114612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M, Paiva B, Montero-Mateo R, Garcia N, Zabaleta A. Epstein-Barr Virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front. Immunol. 12, 656797 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams MV PhD, Cox B, Lafuse WP PhD, Ariza ME. Epstein-Barr virus dUTPase induces neuroinflammatory mediators: implications for myalgic encephalomyelitis/chronic fatigue syndrome. Clin. Ther. 41(5), 848&#x2013;863 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6525645</ArticleId><ArticleId IdType="pubmed">31040055</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, Cortese M, Healy BC et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375(6578), 296&#x2013;301 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35025605</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolis V, Karadedos C, Chiotis I, Chaliasos N, Tsabouri S. Atypical manifestations of Epstein-Barr virus in children: a diagnostic challenge. J. Pediatr. (Rio J). 92(2), 113&#x2013;121 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26802473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lossius A, Johansen JN, Torkildsen &#xd8;, Vartdal F, Holm&#xf8;y T. Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis &#x2013; association and causation. Viruses 4(12), 3701&#x2013;3730 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3528287</ArticleId><ArticleId IdType="pubmed">23342374</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr virus-induced disease. Annu. Rev. Immunol. 33, 787&#x2013;821 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25706097</ArticleId></ArticleIdList></Reference><Reference><Citation>Draborg AH, Duus K, Houen G. Epstein-Barr virus in systemic autoimmune diseases. Clin. Dev. Immunol. 2013, 535738 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3766599</ArticleId><ArticleId IdType="pubmed">24062777</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson F, Jones-Brando L, Ford G et al. Schizophrenia is associated with an aberrant immune response to Epstein-Barr virus. Schizophr. Bull. 45(5), 1112&#x2013;1119 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6737467</ArticleId><ArticleId IdType="pubmed">30462333</ArticleId></ArticleIdList></Reference><Reference><Citation>Behr J, Schaefer M, Littmann E, Klingebiel R, Heinz A. Psychiatric symptoms and cognitive dysfunction caused by Epstein-Barr virus-induced encephalitis. Eur. Psychiatry 21(8), 521&#x2013;522 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17161283</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandaker GM, Stochl J, Zammit S, Lewis G, Jones PB. Childhood Epstein-Barr virus infection and subsequent risk of psychotic experiences in adolescence: A population-based prospective serological study. Schizophrenia Research 158(1&#x2013;3), 19&#x2013;24 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561501</ArticleId><ArticleId IdType="pubmed">25048425</ArticleId></ArticleIdList></Reference><Reference><Citation>Dop D, Marcu IR, Padureanu R, Niculescu CE, Padureanu V. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (review). Exp. Ther. Med. 21(1), 94 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725005</ArticleId><ArticleId IdType="pubmed">33363605</ArticleId></ArticleIdList></Reference><Reference><Citation>Carapetis JR, Beaton A, Cunningham MW et al. Acute rheumatic fever and rheumatic heart disease. Nat. Rev. Dis. Primers 2(1), 1&#x2013;24 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5810582</ArticleId><ArticleId IdType="pubmed">27188830</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigera PC, Rajapakse S, Weeratunga P et al. Dengue and post-infection fatigue: findings from a prospective cohort-the Colombo Dengue Study. Trans. R. Soc. Trop. Med. Hyg. 115(6), 669&#x2013;676 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115379</ArticleId><ArticleId IdType="pubmed">33099653</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952&#x2013;53. I. Clinical features. Trans. R. Soc. Trop. Med. Hyg. 49(1), 28&#x2013;32 (1955).</Citation><ArticleIdList><ArticleId IdType="pubmed">14373834</ArticleId></ArticleIdList></Reference><Reference><Citation>Moro ML, Grilli E, Corvetta A et al. Long-term chikungunya infection clinical manifestations after an outbreak in Italy: a prognostic cohort study. J. Infect. 65(2), 165&#x2013;172 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22522292</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe9;rardin P, Fianu A, Malvy D et al. Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Med. 9, 5 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3029216</ArticleId><ArticleId IdType="pubmed">21235760</ArticleId></ArticleIdList></Reference><Reference><Citation>Word Health Organization. Poliomyelitis (2019). www.who.int/news-room/fact-sheets/detail/poliomyelitis</Citation></Reference><Reference><Citation>Li Hi Shing S, Chipika RH, Finegan E, Murray D, Hardiman O, Bede P. Post-polio Syndrome: more than just a lower motor neuron disease. Front. Neurol. 10, 773 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6646725</ArticleId><ArticleId IdType="pubmed">31379723</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Disease Control and Prevention. Measles (Rubeola). Complication of Measles. www.cdc.gov/measles/symptoms/complications.html</Citation></Reference><Reference><Citation>Gadroen K, Dodd CN, Masclee GMC et al. Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK. BMJ Open 8(11), e021465 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6231568</ArticleId><ArticleId IdType="pubmed">30413497</ArticleId></ArticleIdList></Reference><Reference><Citation>Paules CI, Marston HD, Fauci AS. Measles in 2019 - going backward. N. Engl. J. Med. 380(23), 2185&#x2013;2187 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30995368</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 348(6235), 694&#x2013;699 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4823017</ArticleId><ArticleId IdType="pubmed">25954009</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrova VN, Sawatsky B, Han AX et al. Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles. Sci. Immunol. 4(41), eaay6125 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31672862</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina MJ, Kula T, Leng Y et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science 366(6465), 599&#x2013;606 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590458</ArticleId><ArticleId IdType="pubmed">31672891</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchanan R, Bonthius DJ. Measles virus and associated central nervous system sequelae. Semin. Pediatr. Neurol. 19(3), 107&#x2013;114 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22889539</ArticleId></ArticleIdList></Reference><Reference><Citation>Science Direct. Subacute sclerosing panencephalitis. www.sciencedirect.com/topics/medicine-and-dentistry/subacute-sclerosing-panencephalitis</Citation></Reference><Reference><Citation>Bartley CM, Johns C, Ngo TT et al. Anti-SARS-CoV-2 and autoantibody profiles in the cerebrospinal fluid of 3 teenaged patients with COVID-19 and subacute neuropsychiatric symptoms. JAMA. Neurol. 78(12), 1503&#x2013;1509 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546622</ArticleId><ArticleId IdType="pubmed">34694339</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRovere KL, Riggs BJ, Poussaint TY et al. Overcoming COVID-19 Investigators. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 78(5), 536&#x2013;547 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936352</ArticleId><ArticleId IdType="pubmed">33666649</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 18(9), e1003773 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Wu J, Hao S et al. Long term outcomes in survivors of epidemic Influenza A (H7N9) virus infection. Sci. Rep. 7(1), 17275 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722861</ArticleId><ArticleId IdType="pubmed">29222500</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Jiang H, Xie Y et al. Long-term clinical prognosis of human infections with avian influenza A(H7N9) viruses in China after hospitalization. EClinicalMedicine. 20, 100282 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7152818</ArticleId><ArticleId IdType="pubmed">32300739</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong JC, Schwartz KL, Campitelli MA et al. Acute myocardial Infarction after laboratory-confirmed influenza infection. N. Engl. J. Med. 378(4), 345&#x2013;353 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29365305</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur. Heart J. 29(1), 96&#x2013;103 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18063596</ArticleId></ArticleIdList></Reference><Reference><Citation>Time. What long flu sufferers of the 1918&#x2013;1919 pandemic can tell Us about long covid today. https://time.com/5915616/long-flu-1918-pandemic/</Citation></Reference><Reference><Citation>Hosseini S, Michaelsen-Preusse K, Schughart K, Korte M. Long-term consequence of non-neurotropic H3N2 influenza A virus infection for the progression of Alzheimer's disease symptoms. Front. Cell. Neurosci. 15, 643650 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113629</ArticleId><ArticleId IdType="pubmed">33994946</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini S, Wilk E, Michaelsen-Preusse K et al. Long-term neuroinflammation induced by Influenza A virus infection and the impact on Hippocampal neuron morphology and function. J. Neurosci. 38(12), 3060&#x2013;3080 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6596076</ArticleId><ArticleId IdType="pubmed">29487124</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 324(6), 603&#x2013;605 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L et al. Characterizing long covid in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer RR, Rock MA, Vasilevsky N et al. Characterizing long covid: deep phenotype of a complex condition. EBioMedicine 74, 103722 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made long covid. Soc. Sci. Med. 268, 113426 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, Valentini P et al. Preliminary evidence on long covid in children. Acta. pediatr. 110(7), 2208&#x2013;2211 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta pediatr. 110(3), 914&#x2013;921 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Brackel CLH, Lap CR, Buddingh EP et al. Pediatric long-COVID: an overlooked phenomenon? Pediatr. Pulmonol. 56(8), 2495&#x2013;2502 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242715</ArticleId><ArticleId IdType="pubmed">34102037</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterky E, Olsson-&#xc5;kefeldt S, Hertting O et al. Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta pediatr. 110(9), 2578&#x2013;2580 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444740</ArticleId><ArticleId IdType="pubmed">34157167</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc. Health 5(10), 708&#x2013;718 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P et al. Sechenov StopCOVID Research Team Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J. 59, 2101341 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira L&#xf3;pez J, Grasa C, Calvo C, Garc&#xed;a L&#xf3;pez-Hortelano M. Long-term symptoms of COVID-19 in children. Acta pediatr. 110(7), 2282&#x2013;2283 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251185</ArticleId><ArticleId IdType="pubmed">33745209</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 326(9), 869&#x2013;871 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D, Crawford N, McNab S, Wurzel D, Steer A, Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc. Health 5(6), e22&#x2013;e23 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Smane L, Pucuka Z, Roge I, Pavare J, Stars I. Persistent clinical features in pediatric patients after SARS-CoV-2 virological recovery: a retrospective population-based cohort study from a single centre in Latvia. BMJ pediatrics Open 4(1), e000905 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778738</ArticleId><ArticleId IdType="pubmed">34192185</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala M, Ireland G, Amin-Chowdhury Z, Ramsay ME, Ladhani SN. Acute and persistent symptoms in children with PCR-confirmed SARS-CoV-2 infection compared to test-negative children in England: active, prospective, national surveillance. Clin. Infect. Dis. (2021) (Epub ahead of print).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767867</ArticleId><ArticleId IdType="pubmed">34849658</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. long covid symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur. J. Pediatr. (2022) (Epub ahead of print).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenburg J, Wekenborg MK, Reichert J et al. Mental health of adolescents in the pandemic: Long-COVID19 or long-pandemic syndrome? medRxiv (2021) (Epub ahead of print).</Citation></Reference><Reference><Citation>Buonsenso D, Pujol FE, Munblit D, Mcfarland S, Simpson F. Clinical characteristics, activity levels and mental health problems in children with long covid: a survey of 510 children. Preprints (2021) (Epub ahead of print).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller F, Nguyen V, Navaratnam AM et al. Prevalence of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and Wales. medRxiv (2021) (Epub ahead of print).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9645448</ArticleId><ArticleId IdType="pubmed">36375098</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoke L, Schlegtendal A, Maier C, Eitner L, L&#xfc;cke T, Brinkmann F. More complaints than findings - long-term pulmonary function in children and adolescents after COVID-19. medRxiv (2021) (Epub ahead of print).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9081758</ArticleId><ArticleId IdType="pubmed">35547532</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Shafran R, De Stavola B et al. Long covid and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study). BMJ Open 11(8), e052838 (2021) (Epub ahead of print).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8392739</ArticleId><ArticleId IdType="pubmed">34446502</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Roland D, De Rose C et al. During the COVID-19 pandemic: a catastrophic global situation. Pediatr. Infect. Dis. J. 40(4), e146&#x2013;e150 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33464019</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How common is long covid in children and adolescents? Pediatr. Infect. Dis. J. 40(12), e482&#x2013;e487 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand A, Campion JY, Lepine A et al. Similar patterns of [18F]-FDG brain PET hypometabolism in pediatric and adult patients with long covid: a pediatric case series. Eur. J. Nucl. Med. Mol. Imaging 49(3), 913&#x2013;920 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8376118</ArticleId><ArticleId IdType="pubmed">34414470</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Di Giuda D, Sigfrid L et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child Adolesc. Health 5(9), 677&#x2013;680 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324416</ArticleId><ArticleId IdType="pubmed">34339624</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaco L, Crivellaro C, Cressoni M et al. The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism. Eur. J. Nucl. Med. Mol. Imaging 48(10), 3020&#x2013;3021 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099144</ArticleId><ArticleId IdType="pubmed">33954825</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Pache F, K&#xf6;rtvelyessy P et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J. Neuroinflammation 19(1), 19 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8771621</ArticleId><ArticleId IdType="pubmed">35057809</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendisch D, Dietrich O, Mari T et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 184(26), 6243&#x2013;6261 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8626230</ArticleId><ArticleId IdType="pubmed">34914922</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulfamante G, Bocci T, Falleni M et al. Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung. J. Neurol. 268(12), 4486&#x2013;4491 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129960</ArticleId><ArticleId IdType="pubmed">34003372</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A et al. Post-acute COVID-19 syndrome. Nat. Med. 27(4), 601&#x2013;615 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangisso MH, Woldesemayat EM, Datiko DG, Lindtj&#xf8;rn B. Long-term outcome of smear-positive tuberculosis patients after initiation and completion of treatment: a ten-year retrospective cohort study. PLoS ONE 13(3), e0193396 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846790</ArticleId><ArticleId IdType="pubmed">29529036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruprecht K. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review. Expert Rev. Clin. Immunol. 16(12), 1143&#x2013;1157 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33152255</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin. Microbiol. Rev. 19(1), 80&#x2013;94 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1360274</ArticleId><ArticleId IdType="pubmed">16418524</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J et al. Diverse functional autoantibodies in patients with COVID-19. Nature 595(7866), 283&#x2013;288 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank MG, Nguyen KH, Ball JB et al. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: evidence of PAMP-like properties. Brain Behav. Immun. 100, 267&#x2013;277 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667429</ArticleId><ArticleId IdType="pubmed">34915155</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu JK, Sozmen EG, Dixit K et al. SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy. bioRxiv (2021) (Epub ahead of print).</Citation></Reference><Reference><Citation>Kamp JC, Neubert L, Ackermann M et al. Time-dependent molecular motifs of pulmonary fibrogenesis in COVID-19. Int. J. Mol. Sci. 23(3), 1583 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8835897</ArticleId><ArticleId IdType="pubmed">35163504</ArticleId></ArticleIdList></Reference><Reference><Citation>Milross L, Majo J, Cooper N et al. Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19. Lancet Respir. Med. 10(1), 95&#x2013;106 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8641959</ArticleId><ArticleId IdType="pubmed">34871544</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 19(11), 919&#x2013;929 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Counting the neurological cost of COVID-19. Nat. Rev. Neurol. 18(1), 5&#x2013;6 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8600497</ArticleId><ArticleId IdType="pubmed">34795449</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J, Lampe J, M&#xfc;ller-Fielitz H et al. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat. Neurosci. 24(11), 1522&#x2013;1533 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham EJ, Ren AL, Digby RJ et al. Brain Injury in COVID-19 is associated with autoinflammation and autoimmunity. medRxiv (2021) (Epub ahead of print).</Citation></Reference><Reference><Citation>Gwena&#xeb;lle Douaud, Soojin Lee, Fidel Alfaro-Almagro
et al.
Brain imaging before and after COVID-19 in UK Biobank. https://www.medrxiv.org/content/10.1101/2021.06.11.21258690v3</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.11.21258690v3</ArticleId></ArticleIdList></Reference><Reference><Citation>Donegani MI, Miceli A, Pardini M et al. Brain metabolic correlates of persistent olfactory dysfunction after SARS-Cov2 infection. Biomedicines 9(3), 287 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7998481</ArticleId><ArticleId IdType="pubmed">33808956</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner JO, Warner JA, Munblit D. Hypotheses to explain the associations between asthma and the consequences of COVID-19 infection. Clin. Exp. Allergy 52(1), 7&#x2013;9 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34978737</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik E, Israelow B, Mirza H et al. A humanized mouse model of chronic COVID-19. Nat. Biotechnol. (2021) (Epub ahead of print).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9203605</ArticleId><ArticleId IdType="pubmed">34921308</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Cardona A, Lloreta Trull J, Albero-Gonz&#xe1;lez R et al. SARS-CoV-2 identified by transmission electron microscopy in lymphoproliferative and ischaemic intestinal lesions of COVID-19 patients with acute abdominal pain: two case reports. BMC Gastroenterol. 21(1), 334 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8390036</ArticleId><ArticleId IdType="pubmed">34445965</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow D, Stein S, Ramelli S et al. SARS-CoV-2 infection and persistence throughout the human body and brain. Research square (2021) (Epub ahead of print).</Citation></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R et al. Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front. Immunol. 12, 746021 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Arostegui D, Castro K, Schwarz S et al. Persistent SARS-CoV-2 nucleocapsid protein presence in the intestinal epithelium of a pediatric patient 3 months after acute infection. JPGN Reports. 3(1), 152 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10158423</ArticleId><ArticleId IdType="pubmed">37168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu SX, Tyagi T, Jain K et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat. Rev. Cardiol. 18(3), 194&#x2013;209 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675396</ArticleId><ArticleId IdType="pubmed">33214651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N. Engl. J. Med. 383(2), 120&#x2013;128 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D, Sperhake JP, L&#xfc;tgehetmann M et al. Autopsy findings and venous thromboembolism in patients With COVID-19: a prospective cohort study. Ann. Intern. Med. 173(4), 268&#x2013;277 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Rondina MT. The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases. Front. Immunol. 10, 2204 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6753373</ArticleId><ArticleId IdType="pubmed">31572400</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat. Rev. Nephrol. 17(1), 46&#x2013;64 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7570423</ArticleId><ArticleId IdType="pubmed">33077917</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Wong P, Klein J et al. Longitudinal analyzes reveal immunological misfiring in severe COVID-19. Nature 584(7821), 463&#x2013;469 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D, Giles JR, Baxter AE et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 369, 6508 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 7(6), e438&#x2013;e440 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzaroni MG, Piantoni S, Masneri S et al. Coagulation dysfunction in COVID-19: the interplay between inflammation, viral infection and the coagulation system. Blood. Rev. 46, 100745 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444609</ArticleId><ArticleId IdType="pubmed">32868115</ArticleId></ArticleIdList></Reference><Reference><Citation>Taus F, Salvagno G, Can&#xe8; S et al. Platelets promote thromboinflammation in SARS-CoV-2 pneumonia. Arterioscler. Thromb. Vasc. Biol. 40(12), 2975&#x2013;2989 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682791</ArticleId><ArticleId IdType="pubmed">33052054</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriilaki E, Asteris PG, Touloumenidou T et al. Genetic justification of severe COVID-19 using a rigorous algorithm. Clin. Immunol. 226, 108726 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043057</ArticleId><ArticleId IdType="pubmed">33845193</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaumenhaft R, Enjyoji K, Schmaier AA. Vasculopathy in COVID-19. Blood (2022) (Epub ahead of print).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8736280</ArticleId><ArticleId IdType="pubmed">34986238</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Sullivan JM, Gonagle DM, Ward SE, Preston RJS, O'Donnell JS. Endothelial cells orchestrate COVID-19 coagulopathy. Lancet Haematol. 7(8), e553&#x2013;e555 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326442</ArticleId><ArticleId IdType="pubmed">32619412</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, Pine AB, Meizlish ML et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 7(8), e575&#x2013;e582 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C et al. Persistent clotting protein pathology in long covid/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 20(1), 172 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>ISARIC. ISARIC Global COVID-19 pediatric follow-up
https://isaric.org/research/covid-19-clinical-research-resources/pediatric-follow-up/ (Accessed: 21 February 2022).</Citation></Reference><Reference><Citation>Dhawan RT, Gopalan D, Howard L. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir. Med. 9(1), 107&#x2013;116 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833494</ArticleId><ArticleId IdType="pubmed">33217366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergman P, Lindh AU, Bj&#xf6;rkhem-Bergman L, Lindh JD. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE 8(6), e65835 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3686844</ArticleId><ArticleId IdType="pubmed">23840373</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TTU, Yeom JH, Kim W. Beneficial effects of vitamin E supplementation on endothelial dysfunction, inflammation, and oxidative stress biomarkers in patients receiving hemodialysis: a systematic review and meta-analysis of randomized controlled trials. Int. J. Mol. Sci. 22(21), 11923 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8584391</ArticleId><ArticleId IdType="pubmed">34769353</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong-Tran AQ, Grosser D, Ruffin RE, Murgia C, Zalewski PD. Apoptosis in the normal and inflamed airway epithelium: role of zinc in epithelial protection and procaspase-3 regulation. Biochem. Pharmacol. 66(8), 1459&#x2013;1468 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14555222</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyagbemi AA, Ajibade TO, Aboua YG et al. Potential health benefits of zinc supplementation for the management of COVID-19 pandemic. J. Food Biochem. 45(2), e13604 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7995057</ArticleId><ArticleId IdType="pubmed">33458853</ArticleId></ArticleIdList></Reference><Reference><Citation>Harthill M. Review: micronutrient selenium deficiency influences evolution of some viral infectious diseases. Biol. Trace. Elem. Res. 143(3), 1325&#x2013;1336 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7090490</ArticleId><ArticleId IdType="pubmed">21318622</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbrenner H, Al-Quraishy S, Dkhil MA, Wunderlich F, Sies H. Dietary selenium in adjuvant therapy of viral and bacterial infections. Adv. Nutr. 6(1), 73&#x2013;82 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4288282</ArticleId><ArticleId IdType="pubmed">25593145</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Ehrlich B, Von Ehrlich I. Is Tirschenreuth the Colorado of Germany linking high COVID-19 mortality and low magnesium in drinking water? Magnes. Res. 33(3), 86&#x2013;87 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33210607</ArticleId></ArticleIdList></Reference><Reference><Citation>Alamdari NM, Afaghi S, Rahimi FS et al. Mortality risk factors among hospitalized COVID-19 Patients in a major referral center in Iran. Tohoku J. Exp. Med. 252(1), 73&#x2013;84 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32908083</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Wei J, Huang T et al. Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells. Phytother. Res. 35(3), 1127&#x2013;1129 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753598</ArticleId><ArticleId IdType="pubmed">33222316</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Kashyap P, Chowdhury S, Kumar S, Panwar A, Kumar A. Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication. Phytomedicine 85, 153317 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470885</ArticleId><ArticleId IdType="pubmed">32943302</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahmasebi S, El-Esawi MA, Mahmoud ZH et al. Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients. J. Cell Physiol. 236(7), 5325&#x2013;5338 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Langston-Cox A, Muccini AM, Marshall SA et al. Sulforaphane improves syncytiotrophoblast mitochondrial function after in vitro hypoxic and superoxide injury. Placenta. 96, 44&#x2013;54 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32560857</ArticleId></ArticleIdList></Reference><Reference><Citation>Presti S, Manti S, Parisi GF et al. Lactoferrin: cytokine modulation and application in clinical practice. J. Clin. Med. 10(23), 5482 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8658270</ArticleId><ArticleId IdType="pubmed">34884183</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B, Yogendra R, Osgood E et al. Targeting the monocytic-endothelial-platelet axis with maraviroc and pravastatin as a therapeutic option to treat long covid/post-acute sequelae of COVID (PASC). Research square (2022) (Epub ahead of print).</Citation></Reference><Reference><Citation>Katella K, Yale Medicine. Why vaccines may be helping some with long covid. https://www.yalemedicine.org/news/vaccines-long-covid</Citation></Reference><Reference><Citation>Bradley RE, Ponsford MJ, Scurr MJ, Godkin A, Jolles S. Persistent COVID-19 Infection in Wiskott-Aldrich syndrome cleared following therapeutic vaccination: a case report. J. Clin. Immunol. 42(1), 32&#x2013;35 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8554737</ArticleId><ArticleId IdType="pubmed">34714497</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>